These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22405648)

  • 1. Design and synthesis of novel 5-phenyl-N-piperidine ethanone containing 4,5-dihydropyrazole derivatives as potential antitumor agents.
    Liu XH; Li J; Shi JB; Song BA; Qi XB
    Eur J Med Chem; 2012 May; 51():294-9. PubMed ID: 22405648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity.
    Wu XQ; Huang C; Jia YM; Song BA; Li J; Liu XH
    Eur J Med Chem; 2014 Mar; 74():717-25. PubMed ID: 24119869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents.
    Liu XH; Ruan BF; Liu JX; Song BA; Jing LH; Li J; Yang Y; Zhu HL; Qi XB
    Bioorg Med Chem Lett; 2011 May; 21(10):2916-20. PubMed ID: 21486698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and molecular docking study of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential antitumor agents.
    Liu XH; Liu HF; Chen J; Yang Y; Song BA; Bai LS; Liu JX; Zhu HL; Qi XB
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5705-8. PubMed ID: 20800480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and molecular docking studies of novel 2-chloro-pyridine derivatives containing flavone moieties as potential antitumor agents.
    Liu XH; Liu HF; Shen X; Song BA; Bhadury PS; Zhu HL; Liu JX; Qi XB
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4163-7. PubMed ID: 20538457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
    Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
    Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of novel 2-methyl-4,5-substitutedbenzo[f]-3,3a,4,5-tetrahydro-pyrazolo[1,5-d][1,4]oxazepin-8(7H)-one derivatives as telomerase inhibitors.
    Liu XH; Jia YM; Song BA; Pang ZX; Yang S
    Bioorg Med Chem Lett; 2013 Feb; 23(3):720-3. PubMed ID: 23265905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.
    Zhang XM; Qiu M; Sun J; Zhang YB; Yang YS; Wang XL; Tang JF; Zhu HL
    Bioorg Med Chem; 2011 Nov; 19(21):6518-24. PubMed ID: 21962523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antileukemic activity of novel 2-(4-(2,4-dimethoxybenzoyl)phenoxy)-1-(4-(3-(piperidin-4-yl)propyl)piperidin-1-yl)ethanone derivatives.
    Vinaya K; Kavitha CV; Prasanna DS; Chandrappa S; Ranganatha SR; Raghavan SC; Rangappa KS
    Chem Biol Drug Des; 2012 Mar; 79(3):360-7. PubMed ID: 22181584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of N-phenylsulfonylnicotinamide derivatives as novel antitumor inhibitors.
    Zhang H; Lu X; Zhang LR; Liu JJ; Yang XH; Wang XM; Zhu HL
    Bioorg Med Chem; 2012 Feb; 20(4):1411-6. PubMed ID: 22277588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.
    Shi JB; Tang WJ; Qi XB; Li R; Liu XH
    Eur J Med Chem; 2015 Jan; 90():889-96. PubMed ID: 25554922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of a novel series of 1,3,4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents.
    Puthiyapurayil P; Poojary B; Chikkanna C; Buridipad SK
    Eur J Med Chem; 2012 Jul; 53():203-10. PubMed ID: 22542958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents.
    Huang XF; Lu X; Zhang Y; Song GQ; He QL; Li QS; Yang XH; Wei Y; Zhu HL
    Bioorg Med Chem; 2012 Aug; 20(16):4895-900. PubMed ID: 22819191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of human telomerase inhibitors having the core of N-acyl-4,5-dihydropyrazole with anticancer effects.
    Xiao X; Ni Y; Jia YM; Zheng M; Xu HF; Xu J; Liao C
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1508-1511. PubMed ID: 26883149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological evaluation of novel 4,5-dihydro-2H-pyrazole 2-hydroxyphenyl derivatives as BRAF inhibitors.
    Liu JJ; Zhang H; Sun J; Wang ZC; Yang YS; Li DD; Zhang F; Gong HB; Zhu HL
    Bioorg Med Chem; 2012 Oct; 20(20):6089-96. PubMed ID: 22985957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo.
    Wang Y; Cheng FX; Yuan XL; Tang WJ; Shi JB; Liao CZ; Liu XH
    Eur J Med Chem; 2016 Apr; 112():231-251. PubMed ID: 26900656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety as potential antitumor agents.
    Zheng QZ; Zhang XM; Xu Y; Cheng K; Jiao QC; Zhu HL
    Bioorg Med Chem; 2010 Nov; 18(22):7836-41. PubMed ID: 20947362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
    Sun J; Zhu H; Yang ZM; Zhu HL
    Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.
    Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antileukemic activity of novel 4-(3-(piperidin-4-yl) propyl)piperidine derivatives.
    Vinaya K; Kavitha CV; Chandrappa S; Prasanna DS; Raghavan SC; Rangappa KS
    Chem Biol Drug Des; 2011 Oct; 78(4):622-30. PubMed ID: 21756286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.